ChemoCentryx, Inc.

ChemoCentryx is a focused pharmaceutical company creating first-in-class, orally available medicines for autoimmune diseases, inflammatory disorders and oncology.
By leveraging our pioneering expertise in the field of chemokine research, ChemoCentryx has generated a broad portfolio of medicines targeting the chemokine system, with six product candidates currently in pre-clinical and clinical stages of development. Our pipeline includes: Traficet-EN™ currently in Phase II clinical studies and initially being developed for inflammatory bowel disease. Traficet-EN targets a chemokine receptor called CCR9, which regulates the trafficking of inflammatory cells to the digestive tract. In a separate program, ChemoCentryx intends to take a new drug candidate for multiple sclerosis and cardiovascular disease, targeting the receptor CCR2, into clinical trials this year. Also, two promising compounds targeting novel chemokine receptors are in development for the treatment of cancers. Lastly, ChemoCentryx has two partnered programs. A CCR1 antagonist is being co-developed with Forest Laboratories for autoimmune disorders and CXCR3 receptor antagonists are being developed by ChemoCentryx's partner, Amgen-SF (formerly Tularik).

Contact Details: 850 Maude Avenue Mountain View California 94043 United States of America Tel: 650-210-2900 Fax: 650-210-2910 Email: WWW: www.chemocentryx.com/

Loading...

BioNews Results for ChemoCentryx, Inc.:
Is Bigger Really Better?	Signals Magazine:  Aug 29 2008 3:44AM Matching: chemocentryx inc
Latest News, Developments and Drug Pipelines for Central Nervous System Multiple Sclerosis	Business Wire via Yahoo!:  Jul 17 2008 6:12AM Matching: chemocentryx inc

ChemoCentryx, Inc. Patents:
US Patent No.	Title
7420055	Aryl sulfonamides
7101894	Bicyclic compounds as inhibitors of chemokine binding to US28
7025968	CMV vaccines
6998239	Method for identifying a modulator of the binding of CCX CKR polypeptide to a chemokine
6992084	Compounds and methods for modulating CXCR3 function
→View more ChemoCentryx, Inc. patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 249 times since April 2007, the link to the organisation's website has been followed 40 times

Recent Search Terms used to find this page: chemocentryx | chemocentryx | chemocentryx chemokine sulfonamide | CHEMOCENTRYX. | t | cxcr3 | .

Search for more companies in Mountain View

Search for more companies in California

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for ChemoCentryx, Inc.